Breast Cancer Hormone Treatment: Tamoxifen, other SERMs, and Aromatase Inhibitors

Highlights
Introduction
Risk Factors
Prevention and Lifestyle Factors
Symptoms
Diagnosis
Prognosis
Treatment
Surgery
Radiation
Chemotherapy
Hormone Therapy
Resources
References
References

Resources

www.cancer.gov -- National Cancer Institute
www.cancer.org -- American Cancer Society
www.asco.org -- American Society of Clinical Oncology
www.breastcancer.org -- BreastCancer.Org
www.komen.org -- Susan G. Komen Breast Cancer Foundation
www.nccn.org -- National Comprehensive Cancer Network
www.cancer.net -- Cancer.Net
www.cancer.gov/clinicaltrials -- Find clinical trials

Previous Section

Breast Cancer Hormone Treatment: Tamoxifen, other SERMs, and Aromatase Inhibitors Hormone Therapy

Next Section chevron

Breast Cancer Hormone Treatment: Tamoxifen, other SERMs, and Aromatase Inhibitors References

Review Date: 11/08/2010
Reviewed By: Harvey Simon, MD, Editor-in-Chief, Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)

Breast Cancer Hormone Treatment: Tamoxifen, other SERMs, and Aromatase Inhibitors

Table of Contents

Resources

Ask a Question